Equipment manufacturers
Licence fees from manufacturers of protective sports equipment.
Kinematics and neural signal assessed together, inside the helmet.
The market gap
Every product in protective sports equipment today answers the same question — how hard was the blow. None answers the one that matters to a coach, a physician or a federation: what the brain was doing in the seconds afterwards.
Competition
| Segment | Volume |
|---|---|
| Ice-hockey helmets | 6–8 million a year |
| American football helmets | 5 million a year |
| Cycling helmets | 25 million a year |
| Wearable electronics market | USD 150 billion |
The competition tends to confirm the category rather than occupy this position: all of them are either kinematic or physiological, none neuromorphic.
The solution
Sensors in the shell feed a neuromorphic module built on the CyberSwarm IGZO memristor platform. Impact data and the electrophysiological signal are fused and assessed on the device itself — no cloud, no latency and no dependence on connectivity in the arena.
Partner API
licensing of data and features
Analytics IP
signal fusion and assessment on the device
Neuromorphic module
memristor chip and signal acquisition
Sensors in the shell
6–10 sensors in the helmet
The differentiator is the fusion: kinematics plus neural signal, processed together in real time. Each on its own is known prior art; the combination is not.
The origin of the approach — CyberSwarm supplied the neuromorphic and algorithmic component to the brain-to-vehicle programme of a Japanese carmaker.
Neuromesh holds an exclusive multi-sport licence to that technology.
Beyond sport, the same stack targets industrial and military head protection.
The positioning is deliberate: the system monitors the neurological response. It is not a diagnostic medical device and it does not diagnose concussion.
The model
Neuromesh follows the ARM model. It does not build a factory and does not sell helmets: it licenses the sensing stack to the companies that already make them and to the organisations that set the standards.
Licence fees from manufacturers of protective sports equipment.
Programme licences to federations and leagues that adopt the standard.
API licences for partner platforms using the data layer.
Ice hockey first, then football, cycling and skiing; industrial safety after that.
Intellectual property
A priority application has been filed; the principal claim is the fusion of impact and neurological signal in wearable protective equipment.
The set of claims covers the system, the module, the method, the product, the use and the data platform — including multi-user aggregation via an API.
Extension is planned along the application verticals and through continuation applications — a portfolio is being built, not a single patent.
Development is carried out at the University of Žilina, which is paid for the work, with all resulting IP remaining with Neuromesh.
The patents are at application stage; an expert patentability and freedom-to-operate search is still missing.
Sub-licensing rights under the CyberSwarm licence need to be confirmed before any agreements with manufacturers.
The company is pre-prototype: the seed round funds the proof of concept and the first prototype.
The valuation and the path to a Series A are plans, not commitments.
Leadership
Investment round
The seed round funds the proof of concept and the first prototype. Use of proceeds is set out below.
| Use of proceeds | Amount |
|---|---|
| Prototype and PoC | €500,000 |
| Core team | €450,000 |
| Certification | €300,000 |
| Testing | €300,000 |
| Marketing and ambassadors | €200,000 |
| Legal services | €150,000 |
| Reserve | €100,000 |
Comparable valuations: Bearmind €12–15 million, Prevent Biometrics €20 million and above.
Overview
Pre-prototype stage: the seed round funds the proof of concept and the first prototype. The valuation and the path to a Series A are plans, not commitments.
Investment studies, contractual documentation and the data room are made available to qualified investors after an initial meeting and the signing of an NDA.